Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VULCANO trial of Trinomia versus usual care in high cardiovascular risk patients
2016-004015-13Phase 3Completed
- Sponsor
- Ferrer
- Start
- Dec 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of aspirin + atorvastatin + ramipril in cardiac morbidity (2 arms), sponsored by Ferrer. Primary endpoints: Systolic blood pressure evaluation, LDL cholesterol change and 1 more. Started Dec 2016; status: completed.
02
Drugs
aspirin + atorvastatin + ramipril
03
Conditions
cardiac morbidity
Beyond the preview
Go deeper on 2016-004015-13.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-004015-13.